Metformin as RenoProtector of Progressive Kidney Disease
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 290 participants.
Also called NCT03831464
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 290 participants
- Registry
-
NCT03831464
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Belgium
- Registry status
- Unknown status
Technical summary
Registry record NCT03831464. Randomized; quadruple masking; primary purpose treatment. Start 2019-11-05 (actual); primary completion 2024-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Metformin as RenoProtector of Progressive Kidney Disease
- Acronym
- RenoMet
- Condition
- Chronic Kidney Diseases
- Intervention (Drug)
- Metformin Hydrochloride
- Intervention (Drug)
- Placebo Oral Tablet
- Lead sponsor
- Universiteit Antwerpen
- Collaborator
- University Hospital, Antwerp
Record details
- Record id
cardio:ct-nct03831464- Content hash
c47569f2ce51f43825a2ad2ad835b06b7ad1924b9cc96f4f80020853be2cf312